Center-Authored Papers

Filters: Author is Haagenson, Michael D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Arora M, Weisdorf DJ, Spellman SR, Haagenson MD, Klein JP, Hurley CK, Selby GB, Antin JH, Kernan NA, Kollman C et al..  2009.  HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(10):1644-52. Abstract
C
Cooley S, Weisdorf DJ, Guethlein LA, Klein JP, Wang T, Le CT, Marsh SGE, Geraghty DE, Spellman S, Haagenson MD et al..  2010.  Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.. Blood. 116(14):2411-9. Abstract
J
Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang M-J et al..  2012.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.. Blood. 119(1):296-307. Abstract
L
Lindsley CR, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, Grauman PV, Hu Z-H, Spellman SR, Lee SJ et al..  2017.  Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.. The New England journal of medicine. 376(6):536-547. Abstract
N
Nakasone H, Sahaf B, Tian L, Wang T, Haagenson MD, Schoenrock K, Perloff S, Ryan CE, Wu F, Spellman SR et al..  2015.  Pre-sensitization to HY-antigens in female donors prior to transplant is not associated with male recipient post-transplant HY-antibody development nor clinical outcomes.. Haematologica.
P
Petersdorf EW, Gooley TA, Malkki M, Bacigalupo AP, Cesbron A, Du Toit E, Ehninger G, Egeland T, Fischer GF, Gervais T et al..  2014.  HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.. Blood. 124(26):3996-4003. Abstract
Petersdorf EW, Malkki M, Horowitz MM, Spellman SR, Haagenson MD, Wang T.  2013.  Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation.. Blood. Abstract
Petersdorf EW, Malkki M, O'hUigin C, Carrington M, Gooley T, Haagenson MD, Horowitz MM, Spellman SR, Wang T, Stevenson P.  2015.  High HLA-DP Expression and Graft-versus-Host Disease.. The New England journal of medicine. 373(7):599-609. Abstract
Petersdorf EW, Malkki M, Gooley TA, Spellman SR, Haagenson MD, Horowitz MM, Wang T.  2012.  MHC-Resident Variation Affects Risks After Unrelated Donor Hematopoietic Cell Transplantation.. Science translational medicine. 4(144):144ra101. Abstract
S
Sengsayadeth S, Wang T, Lee SJ, Haagenson MD, Spellman S, Fernandez Viña MA, Muller CR, Verneris MR, Savani BN, Jagasia M.  2014.  Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Single Nucleotide Polymorphisms Are Not Associated with Outcomes after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract